Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T13:45:57.384Z Has data issue: false hasContentIssue false

Prader–Willi syndrome: cycloid psychosis in a genetic subtype?

Published online by Cambridge University Press:  24 June 2014

W. M. A. Verhoeven*
Affiliation:
Vincent van Gogh Institute for Psychiatry, Venray Faculty of Medicine and Medical Sciences, Erasmus University, Rotterdam
S. Tuinier
Affiliation:
Vincent van Gogh Institute for Psychiatry, Venray
L. M. G. Curfs
Affiliation:
Clinical Genetics Center South-East Netherlands, Maastricht, the Netherlands
*
Prof. Dr W.M.A. Verhoeven MD, PhD, Vincent van Gogh Institute for Psychiatry, Stationsweg 46, 5803 AC Venray, the Netherlands. Tel: 31 478 52733; Fax: 31 478 527110

Abstract

Prader–Willi syndrome (PWS) is a genetically determined disorder associated with the loss of the paternal contribution to the proximal part of the long arm of chromosome 15. Its pathophysiology is dominated by hypothalamic dysfunctions. The psychopathological phenotype comprises affective and psychotic symptoms as well as an increase of pre-existent obsessive-compulsive behaviors. The present study comprises 19 PWS patients who were referred for neuropsychiatric evaluation because of psychotic deterioration. Patients were assessed by using the elements of semistructured symptom checklists. In the majority a genetic analysis was performed to detect the underlying chromosomal defect. In 16 of the 19 patients a diagnosis of cycloid psychosis could be established. The other three showed a bipolar affective disorder. Of the psychotic patients, 11 were diagnosed as UPD and one as del 15q11–13. The remaining four patients were diagnosed clinically. For various reasons the genetic etiology could not be established. In PWS patients with a psychotic disorder (cycloid psychosis) a disproportional number of UPD is found.

Type
Research Article
Copyright
Copyright © 2003 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Prader, A, Labhart, A, Willi, H.Ein Syndrom vom Adipositas, Kleinwuchs, Kryptorchismus und Oligophenie nach myatonieartigem Zustand im Neugeborenalter. Schweiz Med Wochenschr 1956;86: 12601261. Google Scholar
Holm, VA, Cassidy, SB, Butler, MGet al. Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91: 398402.Google ScholarPubMed
Gunay-Aygun, M, Schwartz, S, Heeger, S, O'Riordan Cassidy, SB.The changing purpose of Prader–Willi syndrome: clinical diagnostic criteria and proposed revised criteria. Pediatrics 2001;108: 9297. CrossRefGoogle ScholarPubMed
Ledbetter, DH, Riccardi, VM, Airhart, SD, Stobel, RJ, Keenan, BS, Crawford, JD.Deletions of chromosome 15 AS A cause of the Prader–Willi syndrome. N Engl J Med 1981;304: 325329.CrossRefGoogle ScholarPubMed
Butler, MG, Meaney, FJ, Palmer, CG.Clinical and cytogenetic survey of 39 individuals with Prader–Labhart–Willi syndrome. Am J Med Genet 1986;23: 793809.CrossRefGoogle ScholarPubMed
Nicholls, RD, Knoll, JHM, Butler, MG, Karam, S, Lalande, M.Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader–Willi syndrome. Nature 1989;342: 281284.CrossRefGoogle Scholar
Glenn, CC, Driscoll, DJ, Yang, TP, Nicholls, RD.Genomic imprinting. potential function and mechanisms revealed by the Prader–Willi and Angelman syndromes. Mol Hum Reprod 1997;3: 321332.CrossRefGoogle ScholarPubMed
Hanel, M L & Wevrick, R.The role of genomic imprinting in human developmental disorders: lessons from Prader–Willi syndrome. Clin Genet 2001;59: 156164.CrossRefGoogle ScholarPubMed
Cassidy, SB, Forsythe, M, Heeger, Set al. Comparison of phenotype between patients with Prader–Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet 1997;68: 433440.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Roof, E, Stone, W, MacLean, W, Feurer, ID, Thompson, T, Butler, MG.Intellectual characteristics of Prader–Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res 2000;44: 2530.CrossRefGoogle ScholarPubMed
Swaab, DF.Development of the human hypothalamus. Neurochem Res 1995;20: 509519.CrossRefGoogle ScholarPubMed
Miller, L, Angulo, M, Price, D, Taneja, S.MR of the pituitary in patients with Prader–Willi syndrome: size determination and imaging findings. Pediatr Radiol 1996;26: 4347.CrossRefGoogle ScholarPubMed
Hashimoto, T, Mori, K, Yoneda, Yet al. Proton magnetic resonance spectroscopy of the brain in patients with Prader–Willi syndrome. Pediatr Neurol 1998;18: 3035.CrossRefGoogle ScholarPubMed
Gabreëls, BATF, Swaab, DF, Seidah, NG, Van Duijnhoven, HLP, Martens, GJM, Van Leeuwen, FW.Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader(–Labhart)–Willi syndrome patients. Brain Res 1994;657: 281293.CrossRefGoogle ScholarPubMed
Gabreëls, BATF, Swaab, DF, De Kleijn, PVet al. Attenuation of the polypeptide 7B2m prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader–Willi patients: indications for a processing defect. J Clin Endocrinol Metabol 1998;83: 591599. CrossRefGoogle ScholarPubMed
Swaab, DF.Prader–Willi syndrome and the hypothalamus. Acta Paediatr Scand 1997;S423: 5054. CrossRefGoogle Scholar
Åkefeldt, A, Mansson, JE. Is monoamine oxidase activity elevated in Prader–Willi syndrome [brief report]? Eur Child Adolesc Psychiatry 1998;7: 163165.Google ScholarPubMed
ÅKefeldt, A, Ekman, R, Gillberg, C, Mansson, JE.Cerebrospinal fluid monoamines in Prader–Willi syndrome. Biol Psychiatry 1998;44: 13211328.CrossRefGoogle ScholarPubMed
Dykens, EM, Leckman, JF, Cassidy, SB.Obsessions and compulsions in Prader–Willi syndrome. J Child Psychol Psychiatry 1996;37: 9951002.CrossRefGoogle ScholarPubMed
Van Lieshout, CFM, De Meyer, RE, Curfs, LMG, Koot, HM, Frijns, J P.Problem behaviours and personality of children and adolescents with Prader–Willi syndrome. J Pediatr Psychol 1998;23: 111120.CrossRefGoogle ScholarPubMed
Curfs, LMG & Frijns, JP.Prader–Willi Syndrome: a review with special attention to the cognitive and behavioural profile. Birth Defects (original article series) 1992;28: 99104.Google Scholar
Dykens, EM, Hodapp, RM, Walsh, K, Nash, LJ.Profiles, correlates, and trajectories of intelligence in Prader–Willi syndrome. J Am Acad Child Adolesc Psychiatry 1992;31: 11251130.CrossRefGoogle ScholarPubMed
Beardsmore, A, Dorman, T, Cooper, SA, Webb, T.Affective psychosis and Prader–Willi syndrome. J Intellect Disabil Res 1998;42: 463471.CrossRefGoogle ScholarPubMed
Clarke, DJ.Prader–Willi syndrome and psychoses. Br J Psychiatry 1993;163: 680684.CrossRefGoogle ScholarPubMed
Clarke, DJ, Webb, T, Bachmann-Clarke, JP.Prader–Willi syndrome and psychotic symptoms: report of a further case. Ir J Psychol Med 1995;12: 2729. CrossRefGoogle Scholar
Clarke, DJ, Boer, H, Webb, Tet al. Prader–Willi syndrome and psychotic symptoms. I. Case description and genetic studies. J Intellect Disabil Res 1998;42: 440450.CrossRefGoogle Scholar
Skodol, AE, Rosnick, L, Kellman, D, Oldham, JM, Hyler, S.Development of a procedure of validating structured assessments of Axis II. In: Oldham, JM, ed. Personality disorders: new perspectives on diagnostic validity. Washington, American Psychiatric Press, 1991: 4370. Google Scholar
Verhoeven, WMA, Curfs, LMG, Tuinier, S.Prader–Willi syndrome and cycloid psychoses. J Intellect Disabil Res 1998;42: 455462.CrossRefGoogle ScholarPubMed
Verhoeven, WMA, Tuinier, S, Curfs, LMG.Prader–Willi syndrome: a concise review of the genetic, pathophysiological and neuropsychiatric characteristics. In: Franzek, E, Rüther, E, Beckmann, H, Ungvori, GS, eds. Progress in differentiated psychopathology. WKL Schriftenreihe, 2000: 8289. Google Scholar
Verhoeven, WMA, Tuinier, S, Curfs, LMG.Prader–Willi psychiatric syndrome and velo-cardio-facial psychiatric syndrome. Genet Counsel 2000;11: 205213. Google ScholarPubMed
Perris, C & Brockington, IF.Cycloid psychoses and their relation to the major psychoses. In: Perris, C, Struwe, G, Jansson, B, eds. Biological psychiatry. Amsterdam: Elsevier, 1981: 447450. Google Scholar
De Wied, D, Diamant, M, Fodor, M.Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 1993;14: 251302.CrossRefGoogle ScholarPubMed
Olson, BR, Drutarosky, MD, Stricker, EM, Verbalis, JG.Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 1991;129: 785791.CrossRefGoogle ScholarPubMed
McCarthy, MM, Altemus, M.Central nervous system actions of oxytocin and modulation of behaviour in humans. Mol Med Today 1997;3: 269275.CrossRefGoogle ScholarPubMed
Insel, TR.A neurobiological basis of social attachment. Am J Psychiatry 1997;154: 726735.Google ScholarPubMed
Van Wimersma-Greidanus, TB & Maigret, C.The role of limbic vasopressin and oxytocin in social recognition. Brain Res 1996;713: 153159.CrossRefGoogle ScholarPubMed
Engelmann, M, Wotjak, CT, Neumann, I, Ludwig, M, Landgraf, R.Behavioural consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 1996;20: 341358.CrossRefGoogle ScholarPubMed
Deijen, JB, De Boer, H, Blok, GJ, Van der Veen, EA.Cognitive impairment and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996;21: 313322.CrossRefGoogle ScholarPubMed
Eiholzer, U, L'Allemand, D.Growth hormone normalises height, prediction of final height and hand length in children with Prader–Willi syndrome after 4 years of therapy. Horm Res 2000;53: 185192.Google Scholar
Eiholzer, U, Bachmann, S, L'Allemand, D.Is there growth hormone deficiency in Prader–Willi syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader–Willi syndrome. Horm Res 2000 53S3: 44–52.Google Scholar
Altemus, M, Pigott, T, Kalogeras, KTet al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49: 920.CrossRefGoogle ScholarPubMed
Leckman, JF, Goodman, WK, North, WGet al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette's syndrome in healthy controls. Arch Gen Psychiatry 1994;51: 789792. CrossRefGoogle ScholarPubMed
Altemus, M, Swedo, SE, Leonard, HLet al. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry 1994;51: 794803.CrossRefGoogle ScholarPubMed
Piccinelli, M, Pini, S, Bellantuono, C, Wilkinson, G.Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry 1995;166: 424443.CrossRefGoogle ScholarPubMed
Ritzen, EM, Lindgren, AC, Hagenas, L, Marcus, C, Muller, J, Blichfeldt, S.Growth hormone treatment of patients with Prader–Willi syndrome. Swedish Growth Hormone Advisory Group. J Pediatr Endocrinol Metab 1999;12S1: 345349. Google Scholar
Den Boer, JA, Westenberg, HGM.Oxytocin in obsessive compulsive disorder. Peptides 1992;13: 10831085.CrossRefGoogle ScholarPubMed
Egleton, RD, Davis, TP.Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 1997;18: 14311439.CrossRefGoogle Scholar
Boer, H, Holland, A, Whittington, J, Butler, J, Webb, T, Clarke, D.Psychotic illness in people with Prader–Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;12: 359. Google Scholar
Descheemaeker, MJ, Vogels, A, Govers, Vet al. Prader–Willi syndrome: new insights in the behavioural and psychiatric spectrum. J Intellect Disabil Res 2002;46: 4150.CrossRefGoogle ScholarPubMed
Dhossche, DM, Bouman, NH.Catatonia in an adolescent with Prader–Willi syndrome. Ann Clin Psychiatry 1997;9: 247253.CrossRefGoogle Scholar
Pereda Bikanti, M, Antizar Moro, I, Querejeta Ayerdi, I, Andonegi Alday, JI.Psychotic disorder in Prader–Willi syndrome: a case report. Actas Esp Psiquiatr 2001;29: 208212.Google Scholar